September 10th, 1999 - Volume 13 - Issue 13
pp: 1603-1804

Original Papers

Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents

Douglas, Steven D.; Rudy, Bret; Muenz, Larry; More

AIDS. 13(13):1629-1635, September 10th, 1999.

Original Papers

Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children

Funk, Markus B.; Linde, Richard; Wintergerst, Uwe; More

AIDS. 13(13):1653-1658, September 10th, 1999.

CD4 cell counts at the third month of HAART may predict clinical failure

Monforte, Antonella d‚Arminio; Testori, Valeria; Adorni, Fulvio; More

AIDS. 13(13):1669-1676, September 10th, 1999.

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy

Price, Richard W.; Yiannoutsos, Constantin T.; Clifford, David B.; More

AIDS. 13(13):1677-1685, September 10th, 1999.

Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi‚s sarcoma

Bernstein, Zale P.; Wilson, B. Dale; Oseroff, Allan R.; More

AIDS. 13(13):1697-1704, September 10th, 1999.

Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy

Pellegrin, Isabelle; Izopet, Jacques; Reynes, Jacques; More

AIDS. 13(13):1705-1709, September 10th, 1999.

Original Papers

The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women‚s interagency HIV study

Anastos, Kathryn; Kalish, Leslie A.; Hessol, Nancy; More

AIDS. 13(13):1717-1726, September 10th, 1999.

1 2 3 4 5